Sign Out
Zemimet SR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Zemimet SR can be administered: As initial therapy for treatment naive patients with inadequate glycemic control by diet and exercise.
In patients already receiving an identical combination of gemigliptin and metformin as separate tablets.
In patients with inadequate glycemic control with the maximal tolerated dose of metformin monotherapy.
In combination with sulfonylurea in patients with inadequate glycemic control with sulfonylurea and metformin dual therapy.
In combination with insulin in patients with inadequate glycemic control with insulin monotherapy or insulin and metformin dual therapy.
In combination with dapagliflozin in patients with inadequate glycemic control with dapagliflozin and metformin dual therapy.
Continue with Google